Published: December 3rd 2024 | Updated: December 6th 2024
ASH 2024 Preview for Community Oncologists: The Show and After Show
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
Published: February 15th 2025 | Updated: February 19th 2025
Cabozantinib Combo Sustains PFS Benefit in Advanced Kidney Cancer
Published: January 31st 2025 | Updated: February 19th 2025
Common Adverse Events Part 2
Published: January 31st 2025 | Updated: February 19th 2025
Common Adverse Events Part 1
Published: February 16th 2025 | Updated: February 19th 2025
The Targeted Pulse: The Latest FDA Actions Across Cancer Types and Exploring the Efficiency of Remote Pharmacists in Community Oncology